We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

3 Covid-19 Proof Biotech Stocks

08:27am, Monday, 30'th Mar 2020
Covid-19 headlines continue to dominate the headlines and the markets. It is likely to be continue to be rough sledding in the months ahead for investors. Howev
Mar 30, 2020 (The Expresswire) -- Global "Malonic Acid Market" compromises many advantages that have accelerated the adoption of absorption among various...
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Amicus Therapeutics, Inc. (NASDAQ:FOLD)’s stock price dropped 5.3% during trading on Friday . The stock traded as low as $8.73 and last traded at $8.94, approximately 4,287,716 shares changed hands
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index wa

Stocks To Watch: Investors Stay The Distance

01:04pm, Saturday, 28'th Mar 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Great West Life Assurance Co. Can raised its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD) by 32.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exch
Blueshift Asset Management LLC boosted its holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) by 86.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange
Axa boosted its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD) by 1.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The
Amalgamated Bank lifted its position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) by 10.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Secur
Dynamic Technology Lab Private Ltd lessened its position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) by 26.0% during the 4th quarter, according to the company in its most recent Form 13F filing with th
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE